Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Mathieu Beauregard

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 13, 2011
68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphyMichael S Hofman, Jean-Mathieu Beauregard, Thomas W Barber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical TherapiesXinchi Hou, Julia Brosch, Carlos Uribe, et al.
EJNMMI Physics|October 31, 2021
Quantitative SPECT (QSPECT) at high count rates with contemporary SPECT/CT systemsAlessandro Desy, Guillaume F Bouvet, Étienne Croteau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2018
Personalized <sup>177</sup>Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trialMichela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, et al.
European Urology Focus|July 30, 2017
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic TherapyFannie Morin, Jean-Mathieu Beauregard, Michelle Bergeron, et al.
PET Clinics|September 19, 2021
Role of Artificial Intelligence in Theranostics:: Toward Routine Personalized Radiopharmaceutical TherapiesJulia Brosch-Lenz, Fereshteh Yousefirizi, Katherine Zukotynski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2008
[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing miceFrançois Bénard, Naseem Ahmed, Jean-Mathieu Beauregard, et al.
Frontiers in Endocrinology|August 9, 2021
Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With <sup>177</sup>Lu-DOTATATE: A Case ReportAlexis Huot Daneault, Mélanie Desaulniers, Jean-Mathieu Beauregard, et al.
Molecular Imaging and Biology|July 16, 2010
A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumorsNicolas Aide, Kathryn Kinross, Jean-Mathieu Beauregard, et al.
Nuclear Medicine Communications|April 2, 2013
Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesionsJean-Mathieu Beauregard, Anne-Laure Giraudet, Nicolas Aide, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 13, 2011
68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphyMichael S Hofman, Jean-Mathieu Beauregard, Thomas W Barber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical TherapiesXinchi Hou, Julia Brosch, Carlos Uribe, et al.
EJNMMI Physics|October 31, 2021
Quantitative SPECT (QSPECT) at high count rates with contemporary SPECT/CT systemsAlessandro Desy, Guillaume F Bouvet, Étienne Croteau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2018
Personalized <sup>177</sup>Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trialMichela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, et al.
European Urology Focus|July 30, 2017
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic TherapyFannie Morin, Jean-Mathieu Beauregard, Michelle Bergeron, et al.
PET Clinics|September 19, 2021
Role of Artificial Intelligence in Theranostics:: Toward Routine Personalized Radiopharmaceutical TherapiesJulia Brosch-Lenz, Fereshteh Yousefirizi, Katherine Zukotynski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2008
[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing miceFrançois Bénard, Naseem Ahmed, Jean-Mathieu Beauregard, et al.
Frontiers in Endocrinology|August 9, 2021
Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With <sup>177</sup>Lu-DOTATATE: A Case ReportAlexis Huot Daneault, Mélanie Desaulniers, Jean-Mathieu Beauregard, et al.
Molecular Imaging and Biology|July 16, 2010
A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumorsNicolas Aide, Kathryn Kinross, Jean-Mathieu Beauregard, et al.
Nuclear Medicine Communications|April 2, 2013
Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesionsJean-Mathieu Beauregard, Anne-Laure Giraudet, Nicolas Aide, et al.
Pageof 7